How is Ambiq Micro (AMBQ) growing sales 90%?

Sonal Goyal

28 October 2026 05:00 PM AEDT

How is Ambiq Micro (AMBQ) growing sales 90%?

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

Ambiq Micro reported second-quarter 2026 net sales of $33.9 million, up 89.7% from $17.9 million a year earlier.
Cash and cash equivalents were $366.8 million at 30 June 2026 after a June public offering that raised about $168 million in net proceeds.
Third-quarter net sales are guided to $36.0 million to $37.0 million, with a non-GAAP net loss per share of $0.12 to $0.20.

Position and timing

Ambiq Micro (NYSE:AMBQ) last reported results on 11 August 2026, for the quarter ended 30 June. The file name on the company's Investor relations site carries a date of 10 August, but the release itself is dated 11 August. No later results release or confirmed date for third-quarter results has been identified.

The second quarter

Net sales were $33.9 million, up 89.7% from $17.9 million a year earlier, an increase of about $16.0 million. Gross Margin was 45.0% on a GAAP basis and 47.2% non-GAAP. The GAAP net loss was $7.1 million, or $0.32 per share, and the non-GAAP net loss was $1.8 million, or $0.07 per share.

The release did not report non-GAAP operating income.

Funding and listing

In June the company completed an upsized public offering that raised about $168 million in net proceeds. Cash and cash equivalents stood at $366.8 million on 30 June 2026, and 24,146,260 shares were outstanding. The company also announced a dual listing on the Singapore Exchange Main Board under the ticker AMQ.

The cash balance is roughly 50 times the quarter's GAAP net loss of $7.1 million. The release does not set out spending plans in the portion reviewed. Share count matters for per-share comparisons, because the June offering means the number of shares differs between periods.

Products

Ambiq launched heliaCORE and compressionKIT for its Apollo system-on-chip families and announced heliaPROFILER, an open-source profiling tool. The release names no customers or design wins, so it gives no direct evidence of which end markets drove the 89.7% rise in sales. Product announcements are therefore context rather than an explanation of revenue.

Guidance and what to watch

The following is company guidance, not a reported result. For the third quarter of 2026, Ambiq guided to net sales of $36.0 million to $37.0 million, a non-GAAP gross margin of 46.5% to 47.5%, and a non-GAAP net loss per share of between $0.12 and $0.20, based on a weighted average of 24.17 million shares.

The guided loss per share is also wider than the $0.07 non-GAAP loss reported for the second quarter, a change the release does not explain in the portion reviewed.

Points to follow include whether sales land inside the $36.0 million to $37.0 million range, whether non-GAAP gross margin stays near 47%, how the loss per share compares with the guided range, and how cash evolves from $366.8 million. Customer disclosure, the pace of product launches, news about the Singapore listing and the date of the third-quarter report, which is not yet officially confirmed, may also matter.

FAQs

Q: What were Ambiq Micro's second-quarter 2026 results?

A: Net sales were $33.9 million, up 89.7% from $17.9 million. The GAAP net loss was $7.1 million, or $0.32 per share, and the non-GAAP net loss was $1.8 million, or $0.07 per share.

Q: How did Ambiq fund itself and where else will it list?

A: In June it completed an upsized public offering that raised about $168 million in net proceeds, leaving cash of $366.8 million at 30 June 2026. It also announced a dual listing on the Singapore Exchange Main Board under the ticker AMQ.

Q: What is Ambiq's third-quarter guidance?

A: The company guided to net sales of $36.0 million to $37.0 million, a non-GAAP gross margin of 46.5% to 47.5%, and a non-GAAP net loss per share of $0.12 to $0.20.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.